Related references
Note: Only part of the references are listed.Venetoclax for arsenic-resistant acute promyelocytic leukaemia
Qian Qian Wang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission
Yanling Li et al.
ANNALS OF HEMATOLOGY (2022)
Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
Julie Mondet et al.
MOLECULES (2021)
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
Shirin Hafezi et al.
CANCERS (2021)
BCL2 and MCL1 inhibitors for hematologic malignancies
Andrew W. Roberts et al.
BLOOD (2021)
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
Courtney D. DiNardo et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
C. D. DiNardo et al.
BLOOD (2020)
Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients
Julie Mondet et al.
HEMATOLOGICAL ONCOLOGY (2020)
Roles of S100 family members in drug resistance in tumors: Status and prospects
Xin Hua et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points
Naseema Gangat et al.
BLOOD CANCER JOURNAL (2020)
Suppressive effects of S100A8 and S100A9 on neutrophil apoptosis by cytokine release of human bronchial epithelial cells in asthma
Da Hye Kim et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML
Riikka Karjalainen et al.
LEUKEMIA (2019)
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Maximilian Stahl et al.
LEUKEMIA & LYMPHOMA (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Autophagy is Required to Regulate Mitochondria Renewal, Cell Attachment, and All-trans-Retinoic Acid-Induced Differentiation in NB4 Acute Promyelocytic Leukemia Cells
Ibrahim Tekedereli et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2019)
Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
Chulwon Kim et al.
CANCER LETTERS (2018)
S100A9 induces differentiation of acute myeloid leukemia cells through TLR4
Malika Laouedj et al.
BLOOD (2017)
Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells
Rui Wang et al.
CLINICAL CANCER RESEARCH (2016)
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva et al.
CANCER DISCOVERY (2016)
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
G. S. Choudhary et al.
CELL DEATH & DISEASE (2015)
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Rongqing Pan et al.
CANCER DISCOVERY (2014)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Stefan P. Glaser et al.
GENES & DEVELOPMENT (2012)
All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas
Hadas Ben-Sasson et al.
FERTILITY AND STERILITY (2011)
PI3K/Akt: getting it right matters
T. F. Franke
ONCOGENE (2008)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Jiyong Liang et al.
CELL CYCLE (2003)
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
YK Jing et al.
BLOOD (2001)
Share Paper
